Kerry Huntington counts out loud each punch she hurls at the speed bag in front of her, keeping her eyes trained on the ...

Kelechi Wisdom Elechi is a doctoral researcher specialising in ageing neurodegenerative diseases. With a background in pharmacy, his research focuses on the intersection of COVID-19, neurodegeneration ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A recent phase 2 clinical trial reveals that Ambroxol, a common cough medicine, shows promise in stabilizing psychiatric ...

Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

A new study from Stanford Medicine has found that stopping an overactive enzyme in the brain might help protect and even ...

A groundbreaking new study out of Northwestern Medicine may offer new hope for the more than one million Americans living ...

The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...